Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9




Downlaod Files

   


Article Access statistics

Viewed: 1671

PDF Downloaded: 750


Selective cancer treatment by Boron Neutron Capture Therapy (BNCT) – a review


Full Text PDF


Review Article

Author Details : Chiragkumar J. Gohil, Malleshappa N. Noolvi

Volume : 2, Issue : 3, Year : 2015

Article Page : 136-138


Suggest article by email

Get Permission

Abstract

Cancer is the biggest question-mark for the medical science. However many effective drugs are available for the cancer treatment, the biggest obstacle is the selective targeting the drug to the cancer cells. Boron Neutron Capture Therapy (BNCT) is a selective therapy of the cancer, it may not affect or affect little to the normal cells,
It works on 2 principles -
(1)Boron can capture the neutron & getting unstable.
(2) Subsequently nuclear fission of boron occurs via emitting radiation.
So, Delivered the required dose of boron to the cancerous cells and triggering it with the Neutron beam to this cancer cells which contain the boron, This neutron is capture by the neutron of cancer cells, getting unstable & subsequently nuclear fission is occur, this lethal radiation ultimately kills the cancer cells & normal cells are survive.
The nuclear reaction is:
10B + nth ? [11B] ? ? + 7Li + 2.31 MeV
The future prospective are to limit the radiation to the cancer cells only & efficiently deliver the Boron to the cancer cell only, also evaluate the other radioactive materials like Gadolinium in place of Boron.

Keywords: Cancer, BNCT, Boron, Neutron, Nuclear Fission



How to cite : Gohil C J, Noolvi M N, Selective cancer treatment by Boron Neutron Capture Therapy (BNCT) – a review. Int J Pharm Chem Anal 2015;2(3):136-138


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.